Risk factors and treatment outcomes of peristomal pyoderma gangrenosum in patients with inflammatory bowel disease-Reference-Cited by-同舟云学术

Risk factors and treatment outcomes of peristomal pyoderma gangrenosum in patients with inflammatory bowel disease

Published:2020-05-07 Issue:12 Volume:51 Page:1365-1372
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Wang Jingzhou¹^ORCID,Prenner Joshua²,Wang Wenfei¹,Sakuraba Atsushi³^ORCID,Hyman Neil⁴,Dalal Sushila³,Hurst Roger⁴,Cohen Russell D.³,Umanskiy Konstantin⁴,Shogan Benjamin D.⁴,Alpert Lindsay⁵,Rubin David T.³^ORCID,Colwell Janice⁴,Pekow Joel³

Affiliation:

1. Department of Internal Medicine; University of Chicago; Chicago IL USA

2. Pritzker School of Medicine; University of Chicago; Chicago IL USA

3. Section of Gastroenterology, Hepatology, and Nutrition; University of Chicago; Chicago IL USA

4. Department of Surgery; University of Chicago; Chicago IL USA

5. Department of Pathology; University of Chicago; Chicago IL USA

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15766/fullpdf